Maria Shipkova

 

 

  • 2018 – Medical Head Therapeutic Drug Monitoring, Synlab Holding Germany GmbH, MVZ Leinfelden-Echterdingen with teaching appointment at University of Tübingen
  • 2003 -2018 – Senior scientist and Head TDM/Tox Section, Institute of Clinical Chemistry and Laboratory Medicine, Klinikum Stuttgart, Germany
  • 1999- 2002 – Resident Dept. of Clinical Chemistry, University Göttingen, Germany
  • 1995-1999 – Postdoctoral fellow, Dept. of Clinical Chemistry, University Göttingen, Germany
  • 1992-1995 – Resident Dept. of Clinical Chemistry, University Sofia, Bulgaria
  • 1991-1992 – Resident Dept. Internal Medicine, University Sofia, Bulgaria

Academic Degrees:

  • Dr. med. University Göttingen, Germany, 2002
  • D-r (BG)., University Sofia, Bulgaria, 1990

Professional Registrations:

  • Fellow European Board of Laboratory Medicine/Medical Biopathology (F.E.B.L.M./M.B.), 2013
  • Clinical Pathology Consultant, 1996

Professional Society Memberships:

  • Vereinte Deutsche Gesellschaft für Laboratoriumsmedizin und Klinische Chemie (DGKL)
  • International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT)
  • Transplantation Society
  • Bulgarian Academy of Sciences and Arts

Publications:

  • 166 publications contributed to scientific journals and books on the following topics: therapeutic drug monitoring, drug metabolism, drug toxicity, development and evaluation of analytical methods, organ function tests, biomarkers of drug effects

Stipends and Awards:

  • 2015 Grant from the Federal Ministry of Education and Research “Validation of GcfDNA based diagnostic test to detect organ damage after kidney transplantation”
  • 2011 Grant of the Pathobiochemistry and Molecular Diagnostics Foundation, DGKL, Analytical validation of biomarker assays in transplantation medicine
  • 2005 Young Investigator Award of the International Society for Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT)
  • 2004 Grant of the Pathobiochemistry and Molecular Diagnostics Foundation, DGKL, Acyl glucoronides of mycophenolic acid
  • 2002 Grant of the University Göttingen, Germany, Acyl glucuronide of mycophenolic acid
  • 1998 Stipend Volkswagen Foundation, Germany, Metabolism of immunosuppressants
  • 1996 Stipend Otvoreno Obschtestvo, Bulgaria, Pharmacokinetics of Taxol
  • 1995 Tempus Phare stipend of the EU, Therapeutic Drug Monitoring

Varia:

  • Reviews Editor of Therapeutic Drug Monitoring (TDM) (2018 – )
  • Secretary IATDMCT (2017 -2021)
  • Director of Education IATDMCT (2015 – 2017)
  • Vice-Chair IATDMCT Communication Committee (2011 – 2017) and member of the Communication Committee till 2019
  • Member of the IATDMCT Biomarkers in transplantation Working Group (2009 – )
  • Coordinator “TDM of Everolimus” Consensus Project (2013-2016)
  • Past-Chair of the IATDMCT Immunosuppressive Drugs Scientific Committee (2013–2015)
  • Past Editor in Chief of the IATDMCT Newsletter “Compass” (2009 – 2015)
  • Member of the LOC of the 11th IATDMCT Congress, 2011, Stuttgart, Germany
  • Member of the Editorial Boards of Journal of Laboratory Medicine
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.